Loading...

Purified anti-mouse CD45 Antibody Purified anti-mouse CD45 Antibody

Pricing & Availability
Clone
30-F11 (See other available formats)
Regulatory Status
RUO
Other Names
T200, Ly-5, LCA
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
30-F11_Pure_071608.jpg
BALB/c splenocytes stained with 30-F11 purified, followed by anti-rat IgG FITC
  • 30-F11_Pure_071608.jpg
    BALB/c splenocytes stained with 30-F11 purified, followed by anti-rat IgG FITC
  • 30-F11_Pure_CD45_Antibody_2_102518
    Fresh, frozen mouse spleen was stained with purified CD45 clone 30-F11 conjugated and detected with a FITC CODEX™ oligonucleotide duplex (red). Samples were counterstained with CollagenIV Cy5 (green). Data generated at Akoya Biosciences, Inc. using the CODEX™ technology.
Compare all formats
Cat # Size Price Quantity Check Availability Save
103101 50 µg DKK214
Check Availability


Need larger quantities of this item?
Request Bulk Quote
103102 500 µg DKK678
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD45 is a 180-240 kD glycoprotein also known as the leukocyte common antigen (LCA), T200, or Ly-5. It is a member of the protein tyrosine phosphatase (PTP) family, expressed on all hematopoietic cells except mature erythrocytes and platelets. There are different isoforms of CD45 that arise from variable splicing of exons 4, 5, and 6, which encode A, B, and C determinants, respectively. CD45 plays a key role in TCR and BCR signal transduction. These isoforms are very specific to the activation and maturation state of the cell as well as cell type. The primary ligands for CD45 are galectin-1, CD2, CD3, CD4, TCR, CD22, and Thy-1.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse thymus or spleen
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C.
Application

FC - Quality tested
IHC-F, CyTOF® - Verified
IP, CMCD, IHC, WB - Reported in the literature, not verified in house
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Application Notes

Clone 30-F11 reacts with all isoforms and both CD45.1 and CD45.2 alloantigens of CD45.

Additional reported applications (for relevant formats) include: immunoprecipitation3, complement-dependent cytotoxicity1,5, immunohistochemistry (acetone-fixed frozen sections, zinc-fixed paraffin-embedded sections and formalin-fixed paraffin-embedded sections)4,6, Western blotting7, and spatial biology (IBEX)10,11. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 103163 and 103164).

Application References
  1. Podd BS, et al. 2006. J. Immunol. 176:6532. (FC, CMCD) PubMed
  2. Haynes NM, et al. 2007. J. Immunol. 179:5099. (FC)
  3. Ledbetter JA, et al. 1979. Immunol. Rev. 47:63. (IP)
  4. Simon DI, et al. 2000. J. Clin. Invest. 105:293. (IHC)
  5. Seaman WE. 1983. J. Immunol. 130:1713. (CMCD)
  6. Cornet A, et al. 2001. P. Natl. Acad. Sci. USA 98:13306. (IHC)
  7. Tsuboi S and Fukuda M. 1998. J. Biol. Chem. 273:30680. (WB) PubMed
  8. Liu F, et al. 2012. Blood. 119:3295. PubMed
  9. Pelletier AN, et al. 2012. J. Immunol. 188:5561. PubMed
  10. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  11. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Davies M, et al. 2017. PLoS Pathogens. 13(6):e1006435. PubMed
  2. Axelrod HD, et al. 2019. Mol Cancer Res. 17:356. PubMed
  3. Schneider H, et al. 2017. J Neurochem. 140:170. PubMed
  4. Shafer MER, et al. 2017. Stem Cell Reports. 1.040277778. PubMed
  5. Arnold IC, et al. 2019. PLoS Pathog. 15:e1007866. PubMed
  6. Wolf Y, et al. 2017. J Exp Med. 214:905. PubMed
  7. Tarazi S, et al. 2022. Cell. 185:3290. PubMed
  8. Zhao Q, et al. 2023. Signal Transduct Target Ther. 8:40. PubMed
  9. Wang Y, et al. 2023. J Neuroinflammation. 20:41. PubMed
  10. García Fallit M, et al. 2023. Viruses. 15:. PubMed
  11. Xu J, et al. 2023. Discov Oncol. 14:68. PubMed
  12. Rafaiee R, et al. 2023. Bioimpacts. 13:97. PubMed
  13. Hutton C, et al. 2021. Cancer Cell. 39:1227. PubMed
  14. Li F, et al. 2020. EMBO J. 39:e103205. PubMed
  15. Liu CJ, et al. 2020. Neuro Oncol. 22:1276. PubMed
  16. Tremblay M, et al. 2020. Elife. 9: . PubMed
  17. Malinczak CA, et al. 2021. J Immunol. 206:1315. PubMed
  18. Li H, et al. 2022. Cancer Cell. 40:36. PubMed
  19. Ozga AJ, et al. 2022. Immunity. 55:82. PubMed
  20. Moore J, et al. 2022. Cancer Res. 82:365. PubMed
  21. Park JY, et al. 2022. Cell Rep. 38:110219. PubMed
  22. Valet C, et al. 2022. J Clin Invest. 132: . PubMed
  23. Lee NK, et al. 2022. Biomedicines. 10: . PubMed
  24. Moore AR, et al. 2022. Cell Rep. 41:111651. PubMed
  25. Li S, et al. 2022. Nat Commun. 13:7371. PubMed
  26. Abby E, et al. 2023. Nat Genet. 55:232. PubMed
  27. Potempa M, et al. 2022. J Immunol. 208:1742. PubMed
  28. Blomberg E, et al. 2022. Neurooncol Adv. 4:vdac148. PubMed
  29. Murai K, et al. 2022. Nat Commun. 13:6206. PubMed
  30. Hernández-Santana YE, et al. 2020. Life Sci Alliance. 3:00. PubMed
  31. Claveria-Cabello A, et al. 2020. Cancers (Basel). 12:00. PubMed
  32. Vitiello GA, et al. 2018. Clin Cancer Res. 24:972. PubMed
  33. Rothchild AC, et al. 2019. Sci Immunol. 4:eaaw6693. PubMed
  34. Widjaja AA, et al. 2019. Gastroenterology. 157:777. PubMed
  35. Kondo H, et al. 2020. J Biol Chem. 295:1658. PubMed
  36. Fernandes V, et al. 2020. PLoS Pathog. 16:e1008464. PubMed
  37. Nguyen R, et al. 2021. Cancer Immunol Immunother. 70:721. PubMed
  38. Wan Mohd Zawawi WFA, et al. 2021. Sci Rep. 11:10278. PubMed
  39. Maestro S, et al. 2021. Viruses. 13: . PubMed
  40. Reglero-Real N, et al. 2021. Immunity. :. PubMed
  41. Chamberlin T, et al. 2020. Cancer Research. 80(20):4465-4475. PubMed
  42. Li X, et al. 2020. Cell Rep. 31:107765. PubMed
  43. Moon H et al. 2017. Cell stem cell. 21(5):665-678 . PubMed
  44. Rieck M, et al. 2017. Eur J Immunol. 47:677. PubMed
  45. Ajona D, et al. 2017. Cancer Discov. 0.773611111. PubMed
  46. Goel S, et al. 2017. Nature. 548:471. PubMed
  47. Wang W, et al. 2018. Cancer Cell. 34:757. PubMed
  48. Paulo E, et al. 2018. Sci Rep. 8:11001. PubMed
  49. Arnold IC, et al. 2018. J Exp Med. 215:2055. PubMed
  50. Heinrich A, et al. 2021. Cell Rep. 37:109885. PubMed
  51. Cooper STE, et al. 2022. Int J Mol Sci. 23:. PubMed
  52. Deppermann C, et al. 2020. J Exp Med. 217:. PubMed
  53. Lee S, et al. 2020. Cell Host & Microbe. 27(6):937-949. PubMed
  54. Thulasingam S, et al. 2019. Int J Mol Sci. 20. PubMed
  55. Gao J, et al. 2017. Oncol Lett. 14:2954. PubMed
  56. Starossom SC, et al. 2019. Nat Commun. 10:217. PubMed
  57. Dertschnig S, et al. 2020. J Clin Invest. 130:1896. PubMed
  58. Gao H, et al. 2021. J Virol. :. PubMed
  59. Dienz O, et al. 2020. J Immunol. 204:1521. PubMed
  60. Karhadkar TR, et al. 2021. J Pharmacol Exp Ther. 376:106. PubMed
  61. Liu X, et al. 2020. Nature. . PubMed
  62. Altshuler A, et al. 2021. Cell Stem Cell. 28(7):1248-1261.e8. PubMed
  63. Parlanti P, et al. 2020. Exp Eye Res. 194:107998. PubMed
  64. Zabaleta N, et al. 2018. Nat Commun. 9:5454. PubMed
  65. Zhu F, et al. 2019. J Immunol. 203:2644. PubMed
  66. Li Y et al. 2019. Endocrinology. 160(4):938-946 . PubMed
  67. Murad JP, et al. 2018. Front Immunol. 1.95. PubMed
  68. Go DM, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:715. PubMed
  69. Wang G, et al. 2021. Nat Commun. 12:5733. PubMed
  70. Quintana E, et al. 2020. Cancer Res. 80:2889. PubMed
  71. Stefanescu C, et al. 2021. Front Oncol. 11:765151. PubMed
  72. Paprckova D, et al. 2022. Front Immunol. 13:1009198. PubMed
  73. Schafflick D, et al. 2020. Nat Commun. 247:11. PubMed
  74. Podd B, et al. 2006. J Immunol. 176:6532. PubMed
  75. Hitchcock JR, et al. 2020. FEBS J. 287:250. PubMed
  76. McLeod RL, et al. 2018. Oncotarget. 9:34459. PubMed
  77. Sutton C, et al. 2017. Nat Commun.. 10.1038/s41467-017-02111-0. PubMed
  78. Janghorban M, et al. 2022. Cancer Res. 82:885. PubMed
  79. Jackson JW, et al. 2021. Mol Ther Oncolytics. 22:444. PubMed
  80. Mayer KA, et al. 2021. FASEB J. 35:e21217. PubMed
  81. Delgobo M, et al. 2021. Front Immunol. 12:584538. PubMed
  82. Baraibar-Churio A, et al. 2021. Life (Basel). 11:. PubMed
  83. Nam J, et al. 2021. Front Cell Neurosci. 15:640084. PubMed
  84. Park S, et al. 2021. Nat Cell Biol. 23:476. PubMed
  85. Rhee S, et al. 2018. Nat Commun. 9:368. PubMed
  86. Finn J et al. 2019. Cell reports. 26(11):2942-2954 . PubMed
  87. Nolin JD, et al. 2017. JCI Insight. 2:e94929. PubMed
  88. Fiege JK, et al. 2019. PLoS Pathog. 15:e1008077. PubMed
  89. Silvestre-Roig C, et al. 2019. Nature. 569:236. PubMed
  90. Melchor SJ, et al. 2020. Sci Rep. 10:15724. PubMed
  91. O'Dea KP, et al. 2020. J Extracell Vesicles. 9:1706708. PubMed
  92. Baluk P, et al. 2020. Am J Pathol. 190:2355. PubMed
  93. Suzuki Y, et al. 2021. FEBS Open Bio. 11:2619. PubMed
  94. Gil-Melgosa L, et al. 2021. Biomedicines. 10:. PubMed
  95. Hagan AS, et al. 2020. Development. 147:00:00. PubMed
  96. Seelige R, et al. 2018. Sci Rep. 8:13670. PubMed
  97. Yoshihara S, et al. 2019. Front Immunol. 0.545833333. PubMed
  98. Mrdjen D et al. 2018. Immunity. 48(2):380-395 . PubMed
  99. He LD, et al. 2021. EMBO Rep. 22:e52196. PubMed
  100. Yim AKY, et al. 2022. Nat Neurosci. 25:238. PubMed
  101. Singh PP, et al. 2021. Ocul Surf. 21:271. PubMed
  102. Cassidy BR, et al. 2020. J Neuroinflammation. 17:259. PubMed
  103. Karhadkar TR, et al. 2021. PLoS One. 16:e0245924. PubMed
  104. Gereke M, et al. 2012. J Vis Exp. 70: 4322. PubMed
  105. Peralta Ramos JM, et al. 2017. Front Immunol. 1.490277778. PubMed
  106. Ito S, et al. 2020. PLoS One. 15:e0229888. PubMed
  107. Latasa M, et al. 2010. PLoS One. 5:e15690. PubMed
  108. Progatzky F, et al. 2021. Nature. 599:125. PubMed
  109. Bruno KA, et al. 2021. Int J Mol Sci. 22:. PubMed
  110. Crawford LB, et al. 2020. Microorganisms. 8:. PubMed
  111. Liu H, et al. 2020. J Immunol. 205:1207. PubMed
  112. Shokirova H, et al. 2021. Sci Rep. 11:8647. PubMed
  113. Brown IK, et al. 2021. PLoS Pathog. 17:e1009602. PubMed
  114. Fu H, et al. 2020. Front Immunol. 11:595813. PubMed
  115. Qiu X, et al. 2018. Lab Chip. 18:2776. PubMed
  116. Tsubaki T, et al. 2018. Oncotarget. 9:11209. PubMed
  117. Hoves S, et al. 2018. J Exp Med. 215:859. PubMed
  118. Vu LT, et al. 2019. J Extracell Vesicles. 8:1599680. PubMed
  119. Jones KB et al. 2018. Cell stem cell. 24(1):183-192 . PubMed
  120. Zhong L, et al. 2022. JCI Insight. 7:. PubMed
  121. Kenswil KJG, et al. 2021. Cell Stem Cell. 28(4):653-670.e11. PubMed
  122. Zareie P, et al. 2017. J Neuroinflammation. 0.630555556. PubMed
  123. Murai K et al. 2018. Cell stem cell. 23(5):687-699 . PubMed
  124. Morita S et al. 2017. Cell metabolism. 25(4):883-897 . PubMed
  125. Sheppard S, et al. 2018. Front Immunol. 1.630555556. PubMed
  126. Davies CL, et al. 2019. Front Immunol. 10:1048. PubMed
  127. Paharik AE, et al. 2017. Cell Host Microbe. 22:746. PubMed
  128. Johnson SA, et al. 2021. Eur J Immunol. 51:3228. PubMed
  129. Schuler CF, et al. 2020. Allergy. 75:2279. PubMed
  130. Yoon S, et al. 2020. Antioxidants (Basel). 10:. PubMed
  131. Hashimoto M, et al. 2021. J Neurochem. 156:834. PubMed
  132. Tao H, et al. 2021. Front Immunol. 12:623280. PubMed
  133. Scur M, et al. 2022. Nat Commun. 13:7272. PubMed
  134. Nikolaou K, et al. 2014. EMBO J. 34:430. PubMed
  135. Matsuo K, et al. 2018. J Invest Dermatol. 138:1764. PubMed
  136. Bar O, et al. 2020. Fluids Barriers CNS. 17:27. PubMed
  137. Langer V, et al. 2019. J Clin Invest. 129:4691. PubMed
  138. Poulos MG, et al. 2017. J Clin Invest. 127:4163. PubMed
  139. Janela B, et al. 2019. Immunity. 50:1069. PubMed
  140. Lopes N, et al. 2021. Nat Immunol. 22:179. PubMed
  141. Perdigoto AL, et al. 2022. JCI Insight. 7:. PubMed
  142. Ejima R, et al. 2021. Nutrients. 13:. PubMed
  143. Hu CF, et al. 2021. Front Immunol. 12:638381. PubMed
  144. Karhadkar TR, et al. 2020. bioRxiv. . PubMed
  145. Chen Q, et al. 2021. STAR Protocols. 2(1):100241. PubMed
  146. Baluk P, et al. 2018. Methods Mol Biol. 1846:161. PubMed
  147. Fino KK, et al. 2017. Sci Rep. 5.334722222. PubMed
  148. Mensurado S, et al. 2018. PLoS Biol. 16:e2004990. PubMed
  149. Geng T, et al. 2021. J Infect Dis. 223:2186. PubMed
  150. Ishigaki K, et al. 2021. Sci Rep. 11:13958. PubMed
  151. Tsukui H, et al. 2020. BMC Cancer. 20:411. PubMed
  152. Somasundaram R, et al. 2021. Blood. 137:3037. PubMed
  153. Prizant H, et al. 2021. Cell Reports. 36:109523. PubMed
  154. Yu W, et al. 2020. J Clin Invest. . PubMed
  155. Kim D, et al. 2019. Immune Netw. 19:e32. PubMed
  156. Chen X, et al. 2019. Methods Mol Biol. 2048:131. PubMed
  157. Nagatake T, et al. 2018. J Allergy Clin Immunol. 142:470. PubMed
  158. Moon H, et al. 2019. Nat Commun. 10:2225. PubMed
  159. Wang Z, et al. 2021. Drug Discov Ther. 14:304. PubMed
  160. Levy BD, et al. 2020. J Allergy Clin Immunol. 145:335. PubMed
  161. Seo SU, et al. 2021. Front Immunol. 12:697162. PubMed
  162. Roussey JA, et al. 2017. J Immunol. 199:3535. PubMed
  163. Tamburini BAJ, et al. 2019. Front Immunol. 10:1036. PubMed
  164. Dora D, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:1617. PubMed
  165. Fahy N, et al. 2021. Front Immunol. 12:715267. PubMed
  166. Brownlie D, et al. 2021. J Immunother Cancer. 9:. PubMed
  167. Cha J, et al. 2015. J Biol Chem. 290:15337. PubMed
  168. Mori Y, et al. 2021. Diabetes and Vascular Disease Research. 18(3):14791641211027324. PubMed
  169. Rincón E, et al. 2017. Oncotarget. 8:45415. PubMed
  170. Deng W et al. 2019. Cell reports. 27(6):1755-1768 . PubMed
  171. Van Der Zande HJP, et al. 2021. FASEB J. 35:e21331. PubMed
  172. Penny HL, et al. 2021. Int J Mol Sci. 22:. PubMed
  173. Chao Y, et al. 2020. Sci Adv. 6:eaaz4204. PubMed
  174. Lee YJ, et al. 2018. Front Microbiol. 9:83. PubMed
  175. Heinrich A, et al. 2020. Cell Rep. 31:107513. PubMed
  176. Parodi B, et al. 2021. Front Immunol. 12:655212. PubMed
  177. Mohrin M, et al. 2021. Aging Cell. 20:e13313. PubMed
  178. Cané S, et al. 2021. J Immunother Cancer. 9:. PubMed
  179. Udumula MP, et al. 2021. Mol Metab. 53:101272. PubMed
  180. DeFalco T, et al. 2014. Proc Natl Acad Sci U S A. 111:2384. PubMed
  181. Li Y, et al. 2020. Elife. 9:00. PubMed
  182. Diao J, et al. 2018. J Immunol. 201:1306. PubMed
  183. Pushalkar S, et al. 2018. Cancer Discov. 0.613194444. PubMed
  184. Burton OT, et al. 2018. Clin Exp Allergy. 48:288. PubMed
  185. Stokes KL, et al. 2019. Oncogenesis. 8:24. PubMed
  186. Krenzlin H, et al. 2019. J Clin Invest. 130:1671. PubMed
  187. Winter C, et al. 2018. Cell Metab. 28:175. PubMed
  188. Huppé CA, et al. 2018. Mucosal Immunol. 0.536111111. PubMed
  189. Van Winkle JA, et al. 2020. J Virol. 94:. PubMed
  190. Maier B, et al. 2020. Nature. 580:257. PubMed
  191. Wang J, et al. 2021. Am J Cancer Res. 11:2005. PubMed
  192. Aikawa S, et al. 2020. Cell Death Differ. 1489:27. PubMed
  193. Bernard S, et al. 2018. J Mammary Gland Biol Neoplasia. 23:249. PubMed
  194. Leist SR, et al. 2019. PLoS One. 14:e0220126. PubMed
  195. Zhang J, et al. 2019. Onco Targets Ther. 12:4985. PubMed
  196. Hassel C, et al. 2021. Front Immunol. 12:754661. PubMed
  197. Obst J, et al. 2020. Front Immunol. 11:579000. PubMed
  198. Dubik M, et al. 2021. Front Neurosci. 15:682451. PubMed
  199. Kästle M, et al. 2020. Cell Commun Signal. 183:18. PubMed
  200. Shao Y, et al. 2017. Onco Targets Ther. 10:2675. PubMed
  201. He X, et al. 2017. Cancer Biol Ther. 0.815277778. PubMed
  202. Haber AL, et al. 2017. Nature. 551:333. PubMed
  203. Emrick JJ, et al. 2018. Proc Natl Acad Sci U S A. 115:E12091. PubMed
  204. Seehus CR, et al. 2017. Nat Commun. 8:1900. PubMed
  205. Cédile O, Wlodarczyk A, and Owens T 2017. APMIS.. 10.1111/apm.12740. PubMed
  206. Wilke JBH, et al. 2021. Mol Psychiatry. 26:7746. PubMed
  207. Umeda M, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  208. Kästele V, et al. 2021. Mucosal Immunol. 14:717. PubMed
  209. Davies M, et al. 2017. PLoS Pathogens. 13(6):e1006435. PubMed
  210. Axelrod HD, et al. 2019. Mol Cancer Res. 17:356. PubMed
  211. Schneider H, et al. 2017. J Neurochem. 140:170. PubMed
  212. Shafer MER, et al. 2017. Stem Cell Reports. 1.040277778. PubMed
  213. Arnold IC, et al. 2019. PLoS Pathog. 15:e1007866. PubMed
  214. Wolf Y, et al. 2017. J Exp Med. 214:905. PubMed
  215. Tarazi S, et al. 2022. Cell. 185:3290. PubMed
  216. Zhao Q, et al. 2023. Signal Transduct Target Ther. 8:40. PubMed
  217. Wang Y, et al. 2023. J Neuroinflammation. 20:41. PubMed
  218. García Fallit M, et al. 2023. Viruses. 15:. PubMed
  219. Xu J, et al. 2023. Discov Oncol. 14:68. PubMed
  220. Rafaiee R, et al. 2023. Bioimpacts. 13:97. PubMed
  221. Hutton C, et al. 2021. Cancer Cell. 39:1227. PubMed
  222. Li F, et al. 2020. EMBO J. 39:e103205. PubMed
  223. Liu CJ, et al. 2020. Neuro Oncol. 22:1276. PubMed
  224. Tremblay M, et al. 2020. Elife. 9: . PubMed
  225. Malinczak CA, et al. 2021. J Immunol. 206:1315. PubMed
  226. Li H, et al. 2022. Cancer Cell. 40:36. PubMed
  227. Ozga AJ, et al. 2022. Immunity. 55:82. PubMed
  228. Moore J, et al. 2022. Cancer Res. 82:365. PubMed
  229. Park JY, et al. 2022. Cell Rep. 38:110219. PubMed
  230. Valet C, et al. 2022. J Clin Invest. 132: . PubMed
  231. Lee NK, et al. 2022. Biomedicines. 10: . PubMed
  232. Moore AR, et al. 2022. Cell Rep. 41:111651. PubMed
  233. Li S, et al. 2022. Nat Commun. 13:7371. PubMed
  234. Abby E, et al. 2023. Nat Genet. 55:232. PubMed
  235. Potempa M, et al. 2022. J Immunol. 208:1742. PubMed
  236. Blomberg E, et al. 2022. Neurooncol Adv. 4:vdac148. PubMed
  237. Murai K, et al. 2022. Nat Commun. 13:6206. PubMed
  238. Hernández-Santana YE, et al. 2020. Life Sci Alliance. 3:00. PubMed
  239. Claveria-Cabello A, et al. 2020. Cancers (Basel). 12:00. PubMed
  240. Vitiello GA, et al. 2018. Clin Cancer Res. 24:972. PubMed
  241. Rothchild AC, et al. 2019. Sci Immunol. 4:eaaw6693. PubMed
  242. Widjaja AA, et al. 2019. Gastroenterology. 157:777. PubMed
  243. Kondo H, et al. 2020. J Biol Chem. 295:1658. PubMed
  244. Fernandes V, et al. 2020. PLoS Pathog. 16:e1008464. PubMed
  245. Nguyen R, et al. 2021. Cancer Immunol Immunother. 70:721. PubMed
  246. Wan Mohd Zawawi WFA, et al. 2021. Sci Rep. 11:10278. PubMed
  247. Maestro S, et al. 2021. Viruses. 13: . PubMed
  248. Reglero-Real N, et al. 2021. Immunity. :. PubMed
  249. Chamberlin T, et al. 2020. Cancer Research. 80(20):4465-4475. PubMed
  250. Li X, et al. 2020. Cell Rep. 31:107765. PubMed
  251. Moon H et al. 2017. Cell stem cell. 21(5):665-678 . PubMed
  252. Rieck M, et al. 2017. Eur J Immunol. 47:677. PubMed
  253. Ajona D, et al. 2017. Cancer Discov. 0.773611111. PubMed
  254. Goel S, et al. 2017. Nature. 548:471. PubMed
  255. Wang W, et al. 2018. Cancer Cell. 34:757. PubMed
  256. Paulo E, et al. 2018. Sci Rep. 8:11001. PubMed
  257. Arnold IC, et al. 2018. J Exp Med. 215:2055. PubMed
  258. Heinrich A, et al. 2021. Cell Rep. 37:109885. PubMed
  259. Cooper STE, et al. 2022. Int J Mol Sci. 23:. PubMed
  260. Deppermann C, et al. 2020. J Exp Med. 217:. PubMed
  261. Lee S, et al. 2020. Cell Host & Microbe. 27(6):937-949. PubMed
  262. Thulasingam S, et al. 2019. Int J Mol Sci. 20. PubMed
  263. Gao J, et al. 2017. Oncol Lett. 14:2954. PubMed
  264. Starossom SC, et al. 2019. Nat Commun. 10:217. PubMed
  265. Dertschnig S, et al. 2020. J Clin Invest. 130:1896. PubMed
  266. Gao H, et al. 2021. J Virol. :. PubMed
  267. Dienz O, et al. 2020. J Immunol. 204:1521. PubMed
  268. Karhadkar TR, et al. 2021. J Pharmacol Exp Ther. 376:106. PubMed
  269. Liu X, et al. 2020. Nature. . PubMed
  270. Altshuler A, et al. 2021. Cell Stem Cell. 28(7):1248-1261.e8. PubMed
  271. Parlanti P, et al. 2020. Exp Eye Res. 194:107998. PubMed
  272. Zabaleta N, et al. 2018. Nat Commun. 9:5454. PubMed
  273. Zhu F, et al. 2019. J Immunol. 203:2644. PubMed
  274. Li Y et al. 2019. Endocrinology. 160(4):938-946 . PubMed
  275. Murad JP, et al. 2018. Front Immunol. 1.95. PubMed
  276. Go DM, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:715. PubMed
  277. Wang G, et al. 2021. Nat Commun. 12:5733. PubMed
  278. Quintana E, et al. 2020. Cancer Res. 80:2889. PubMed
  279. Stefanescu C, et al. 2021. Front Oncol. 11:765151. PubMed
  280. Paprckova D, et al. 2022. Front Immunol. 13:1009198. PubMed
  281. Schafflick D, et al. 2020. Nat Commun. 247:11. PubMed
  282. Podd B, et al. 2006. J Immunol. 176:6532. PubMed
  283. Hitchcock JR, et al. 2020. FEBS J. 287:250. PubMed
  284. McLeod RL, et al. 2018. Oncotarget. 9:34459. PubMed
  285. Sutton C, et al. 2017. Nat Commun.. 10.1038/s41467-017-02111-0. PubMed
  286. Janghorban M, et al. 2022. Cancer Res. 82:885. PubMed
  287. Jackson JW, et al. 2021. Mol Ther Oncolytics. 22:444. PubMed
  288. Mayer KA, et al. 2021. FASEB J. 35:e21217. PubMed
  289. Delgobo M, et al. 2021. Front Immunol. 12:584538. PubMed
  290. Baraibar-Churio A, et al. 2021. Life (Basel). 11:. PubMed
  291. Nam J, et al. 2021. Front Cell Neurosci. 15:640084. PubMed
  292. Park S, et al. 2021. Nat Cell Biol. 23:476. PubMed
  293. Rhee S, et al. 2018. Nat Commun. 9:368. PubMed
  294. Finn J et al. 2019. Cell reports. 26(11):2942-2954 . PubMed
  295. Nolin JD, et al. 2017. JCI Insight. 2:e94929. PubMed
  296. Fiege JK, et al. 2019. PLoS Pathog. 15:e1008077. PubMed
  297. Silvestre-Roig C, et al. 2019. Nature. 569:236. PubMed
  298. Melchor SJ, et al. 2020. Sci Rep. 10:15724. PubMed
  299. O'Dea KP, et al. 2020. J Extracell Vesicles. 9:1706708. PubMed
  300. Baluk P, et al. 2020. Am J Pathol. 190:2355. PubMed
  301. Suzuki Y, et al. 2021. FEBS Open Bio. 11:2619. PubMed
  302. Gil-Melgosa L, et al. 2021. Biomedicines. 10:. PubMed
  303. Hagan AS, et al. 2020. Development. 147:00:00. PubMed
  304. Seelige R, et al. 2018. Sci Rep. 8:13670. PubMed
  305. Yoshihara S, et al. 2019. Front Immunol. 0.545833333. PubMed
  306. Mrdjen D et al. 2018. Immunity. 48(2):380-395 . PubMed
  307. He LD, et al. 2021. EMBO Rep. 22:e52196. PubMed
  308. Yim AKY, et al. 2022. Nat Neurosci. 25:238. PubMed
  309. Singh PP, et al. 2021. Ocul Surf. 21:271. PubMed
  310. Cassidy BR, et al. 2020. J Neuroinflammation. 17:259. PubMed
  311. Karhadkar TR, et al. 2021. PLoS One. 16:e0245924. PubMed
  312. Gereke M, et al. 2012. J Vis Exp. 70: 4322. PubMed
  313. Peralta Ramos JM, et al. 2017. Front Immunol. 1.490277778. PubMed
  314. Ito S, et al. 2020. PLoS One. 15:e0229888. PubMed
  315. Latasa M, et al. 2010. PLoS One. 5:e15690. PubMed
  316. Progatzky F, et al. 2021. Nature. 599:125. PubMed
  317. Bruno KA, et al. 2021. Int J Mol Sci. 22:. PubMed
  318. Crawford LB, et al. 2020. Microorganisms. 8:. PubMed
  319. Liu H, et al. 2020. J Immunol. 205:1207. PubMed
  320. Shokirova H, et al. 2021. Sci Rep. 11:8647. PubMed
  321. Brown IK, et al. 2021. PLoS Pathog. 17:e1009602. PubMed
  322. Fu H, et al. 2020. Front Immunol. 11:595813. PubMed
  323. Qiu X, et al. 2018. Lab Chip. 18:2776. PubMed
  324. Tsubaki T, et al. 2018. Oncotarget. 9:11209. PubMed
  325. Hoves S, et al. 2018. J Exp Med. 215:859. PubMed
  326. Vu LT, et al. 2019. J Extracell Vesicles. 8:1599680. PubMed
  327. Jones KB et al. 2018. Cell stem cell. 24(1):183-192 . PubMed
  328. Zhong L, et al. 2022. JCI Insight. 7:. PubMed
  329. Kenswil KJG, et al. 2021. Cell Stem Cell. 28(4):653-670.e11. PubMed
  330. Zareie P, et al. 2017. J Neuroinflammation. 0.630555556. PubMed
  331. Murai K et al. 2018. Cell stem cell. 23(5):687-699 . PubMed
  332. Morita S et al. 2017. Cell metabolism. 25(4):883-897 . PubMed
  333. Sheppard S, et al. 2018. Front Immunol. 1.630555556. PubMed
  334. Davies CL, et al. 2019. Front Immunol. 10:1048. PubMed
  335. Paharik AE, et al. 2017. Cell Host Microbe. 22:746. PubMed
  336. Johnson SA, et al. 2021. Eur J Immunol. 51:3228. PubMed
  337. Schuler CF, et al. 2020. Allergy. 75:2279. PubMed
  338. Yoon S, et al. 2020. Antioxidants (Basel). 10:. PubMed
  339. Hashimoto M, et al. 2021. J Neurochem. 156:834. PubMed
  340. Tao H, et al. 2021. Front Immunol. 12:623280. PubMed
  341. Scur M, et al. 2022. Nat Commun. 13:7272. PubMed
  342. Nikolaou K, et al. 2014. EMBO J. 34:430. PubMed
  343. Matsuo K, et al. 2018. J Invest Dermatol. 138:1764. PubMed
  344. Bar O, et al. 2020. Fluids Barriers CNS. 17:27. PubMed
  345. Langer V, et al. 2019. J Clin Invest. 129:4691. PubMed
  346. Poulos MG, et al. 2017. J Clin Invest. 127:4163. PubMed
  347. Janela B, et al. 2019. Immunity. 50:1069. PubMed
  348. Lopes N, et al. 2021. Nat Immunol. 22:179. PubMed
  349. Perdigoto AL, et al. 2022. JCI Insight. 7:. PubMed
  350. Ejima R, et al. 2021. Nutrients. 13:. PubMed
  351. Hu CF, et al. 2021. Front Immunol. 12:638381. PubMed
  352. Karhadkar TR, et al. 2020. bioRxiv. . PubMed
  353. Chen Q, et al. 2021. STAR Protocols. 2(1):100241. PubMed
  354. Baluk P, et al. 2018. Methods Mol Biol. 1846:161. PubMed
  355. Fino KK, et al. 2017. Sci Rep. 5.334722222. PubMed
  356. Mensurado S, et al. 2018. PLoS Biol. 16:e2004990. PubMed
  357. Geng T, et al. 2021. J Infect Dis. 223:2186. PubMed
  358. Ishigaki K, et al. 2021. Sci Rep. 11:13958. PubMed
  359. Tsukui H, et al. 2020. BMC Cancer. 20:411. PubMed
  360. Somasundaram R, et al. 2021. Blood. 137:3037. PubMed
  361. Prizant H, et al. 2021. Cell Reports. 36:109523. PubMed
  362. Yu W, et al. 2020. J Clin Invest. . PubMed
  363. Kim D, et al. 2019. Immune Netw. 19:e32. PubMed
  364. Chen X, et al. 2019. Methods Mol Biol. 2048:131. PubMed
  365. Nagatake T, et al. 2018. J Allergy Clin Immunol. 142:470. PubMed
  366. Moon H, et al. 2019. Nat Commun. 10:2225. PubMed
  367. Wang Z, et al. 2021. Drug Discov Ther. 14:304. PubMed
  368. Levy BD, et al. 2020. J Allergy Clin Immunol. 145:335. PubMed
  369. Seo SU, et al. 2021. Front Immunol. 12:697162. PubMed
  370. Roussey JA, et al. 2017. J Immunol. 199:3535. PubMed
  371. Tamburini BAJ, et al. 2019. Front Immunol. 10:1036. PubMed
  372. Dora D, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:1617. PubMed
  373. Fahy N, et al. 2021. Front Immunol. 12:715267. PubMed
  374. Brownlie D, et al. 2021. J Immunother Cancer. 9:. PubMed
  375. Cha J, et al. 2015. J Biol Chem. 290:15337. PubMed
  376. Mori Y, et al. 2021. Diabetes and Vascular Disease Research. 18(3):14791641211027324. PubMed
  377. Rincón E, et al. 2017. Oncotarget. 8:45415. PubMed
  378. Deng W et al. 2019. Cell reports. 27(6):1755-1768 . PubMed
  379. Van Der Zande HJP, et al. 2021. FASEB J. 35:e21331. PubMed
  380. Penny HL, et al. 2021. Int J Mol Sci. 22:. PubMed
  381. Chao Y, et al. 2020. Sci Adv. 6:eaaz4204. PubMed
  382. Lee YJ, et al. 2018. Front Microbiol. 9:83. PubMed
  383. Heinrich A, et al. 2020. Cell Rep. 31:107513. PubMed
  384. Parodi B, et al. 2021. Front Immunol. 12:655212. PubMed
  385. Mohrin M, et al. 2021. Aging Cell. 20:e13313. PubMed
  386. Cané S, et al. 2021. J Immunother Cancer. 9:. PubMed
  387. Udumula MP, et al. 2021. Mol Metab. 53:101272. PubMed
  388. DeFalco T, et al. 2014. Proc Natl Acad Sci U S A. 111:2384. PubMed
  389. Li Y, et al. 2020. Elife. 9:00. PubMed
  390. Diao J, et al. 2018. J Immunol. 201:1306. PubMed
  391. Pushalkar S, et al. 2018. Cancer Discov. 0.613194444. PubMed
  392. Burton OT, et al. 2018. Clin Exp Allergy. 48:288. PubMed
  393. Stokes KL, et al. 2019. Oncogenesis. 8:24. PubMed
  394. Krenzlin H, et al. 2019. J Clin Invest. 130:1671. PubMed
  395. Winter C, et al. 2018. Cell Metab. 28:175. PubMed
  396. Huppé CA, et al. 2018. Mucosal Immunol. 0.536111111. PubMed
  397. Van Winkle JA, et al. 2020. J Virol. 94:. PubMed
  398. Maier B, et al. 2020. Nature. 580:257. PubMed
  399. Wang J, et al. 2021. Am J Cancer Res. 11:2005. PubMed
  400. Aikawa S, et al. 2020. Cell Death Differ. 1489:27. PubMed
  401. Bernard S, et al. 2018. J Mammary Gland Biol Neoplasia. 23:249. PubMed
  402. Leist SR, et al. 2019. PLoS One. 14:e0220126. PubMed
  403. Zhang J, et al. 2019. Onco Targets Ther. 12:4985. PubMed
  404. Hassel C, et al. 2021. Front Immunol. 12:754661. PubMed
  405. Obst J, et al. 2020. Front Immunol. 11:579000. PubMed
  406. Dubik M, et al. 2021. Front Neurosci. 15:682451. PubMed
  407. Kästle M, et al. 2020. Cell Commun Signal. 183:18. PubMed
  408. Shao Y, et al. 2017. Onco Targets Ther. 10:2675. PubMed
  409. He X, et al. 2017. Cancer Biol Ther. 0.815277778. PubMed
  410. Haber AL, et al. 2017. Nature. 551:333. PubMed
  411. Emrick JJ, et al. 2018. Proc Natl Acad Sci U S A. 115:E12091. PubMed
  412. Seehus CR, et al. 2017. Nat Commun. 8:1900. PubMed
  413. Cédile O, Wlodarczyk A, and Owens T 2017. APMIS.. 10.1111/apm.12740. PubMed
  414. Wilke JBH, et al. 2021. Mol Psychiatry. 26:7746. PubMed
  415. Umeda M, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  416. Kästele V, et al. 2021. Mucosal Immunol. 14:717. PubMed
RRID
AB_312966 (BioLegend Cat. No. 103101)
AB_312967 (BioLegend Cat. No. 103102)

Antigen Details

Structure
Protein tyrosine phosphatase (PTP) family, 180-240 kD
Distribution

All hematopoietic cells except mature erythrocytes and platelets

Function
Phosphatase, T and B cell activation
Ligand/Receptor
Galectin-1, CD2, CD3, CD4, TCR, CD22, Thy-1
Cell Type
B cells, Dendritic cells, Mesenchymal Stem Cells, Tregs
Biology Area
Cell Biology, Immunology, Inhibitory Molecules, Innate Immunity, Neuroscience, Neuroscience Cell Markers, Stem Cells
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Trowbridge IS, et al. 1993. Annu. Rev. Immunol. 12:85.
3. Kishihara K, et al. 1993. Cell 74:143.
4. Pulido R, et al. 1988. J. Immunol. 140:3851.

Gene ID
19264 View all products for this Gene ID
UniProt
View information about CD45 on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD45 Reagents Request Custom Conjugation
Description Clone Applications
PE anti-mouse CD45 30-F11 FC
PE/Cyanine5 anti-mouse CD45 30-F11 FC
Purified anti-mouse CD45 30-F11 FC,IHC-F,CyTOF®,IP,CMCD,IHC,WB
PE/Cyanine7 anti-mouse CD45 30-F11 FC
PE/Dazzle™ 594 anti-mouse CD45 30-F11 FC
Brilliant Violet 711™ anti-mouse CD45 30-F11 FC
Brilliant Violet 785™ anti-mouse CD45 30-F11 FC
Brilliant Violet 650™ anti-mouse CD45 30-F11 FC
APC/Fire™ 750 anti-mouse CD45 30-F11 FC
Brilliant Violet 750™ anti-mouse CD45 30-F11 FC
TotalSeq™-A0096 anti-mouse CD45 30-F11 PG
TotalSeq™-B0096 anti-mouse CD45 30-F11 PG
Ultra-LEAF™ Purified anti-mouse CD45 30-F11 FC,CyTOF®,IP,CMCD,IHC,WB
Spark Blue™ 550 anti-mouse CD45 30-F11 FC
Spark NIR™ 685 anti-mouse CD45 30-F11 FC
TotalSeq™-C0096 anti-mouse CD45 30-F11 PG
Spark YG™ 570 anti-mouse CD45 30-F11 IHC-F
PE/Fire™ 640 anti-mouse CD45 30-F11 FC
APC/Fire™ 810 anti-mouse CD45 30-F11 FC
PE/Fire™ 700 anti-mouse CD45 30-F11 FC
APC anti-mouse CD45 30-F11 FC
Biotin anti-mouse CD45 30-F11 FC
FITC anti-mouse CD45 30-F11 FC
APC/Cyanine7 anti-mouse CD45 30-F11 FC
Alexa Fluor® 488 anti-mouse CD45 30-F11 FC,SB
Alexa Fluor® 647 anti-mouse CD45 30-F11 FC,ICC,IHC,3D IHC,SB
Pacific Blue™ anti-mouse CD45 30-F11 FC
Alexa Fluor® 700 anti-mouse CD45 30-F11 FC,SB
PerCP/Cyanine5.5 anti-mouse CD45 30-F11 FC
PerCP anti-mouse CD45 30-F11 FC
Alexa Fluor® 594 anti-mouse CD45 30-F11 IHC-F,FC,3D IHC
Brilliant Violet 421™ anti-mouse CD45 30-F11 FC,SB
Brilliant Violet 570™ anti-mouse CD45 30-F11 FC
Brilliant Violet 510™ anti-mouse CD45 30-F11 FC
Brilliant Violet 605™ anti-mouse CD45 30-F11 FC
Purified anti-mouse CD45 (Maxpar® Ready) 30-F11 FC,CyTOF®
Spark Violet™ 538 anti-mouse CD45 30-F11 FC
Spark YG™ 593 anti-mouse CD45 30-F11 FC
Spark Blue™ 574 anti-mouse CD45 Antibody 30-F11 FC
Spark Blue™ 515 anti-mouse CD45 30-F11 FC
Spark UV™ 387 anti-mouse CD45 30-F11 FC
PE/Fire™ 810 anti-mouse CD45 30-F11 FC
Spark PLUS UV395™ anti-mouse CD45 30-F11 FC
Spark Red™ 718 anti-mouse CD45 30-F11 FC
Spark YG™ 581 anti-mouse CD45 (Flexi-Fluor™) 30-F11 FC
Spark PLUS V475™ anti-mouse CD45 Antibody 30-F11 FC
StarBright UltraViolet 740 anti-mouse CD45 30-F11 FC
Go To Top Version: 3    Revision Date: 10/25/2018

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

Pricing & Availability
Clone
30-F11 (See other available formats)
Regulatory Status
RUO
Other Names
T200, Ly-5, LCA
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
30-F11_Pure_071608.jpg
BALB/c splenocytes stained with 30-F11 purified, followed by anti-rat IgG FITC
  • 30-F11_Pure_071608.jpg
    BALB/c splenocytes stained with 30-F11 purified, followed by anti-rat IgG FITC
  • 30-F11_Pure_CD45_Antibody_2_102518
    Fresh, frozen mouse spleen was stained with purified CD45 clone 30-F11 conjugated and detected with a FITC CODEX™ oligonucleotide duplex (red). Samples were counterstained with CollagenIV Cy5 (green). Data generated at Akoya Biosciences, Inc. using the CODEX™ technology.
Compare all formats
Cat # Size Price Quantity Check Availability Save
103101 50 µg DKK214
Check Availability


Need larger quantities of this item?
Request Bulk Quote
103102 500 µg DKK678
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD45 is a 180-240 kD glycoprotein also known as the leukocyte common antigen (LCA), T200, or Ly-5. It is a member of the protein tyrosine phosphatase (PTP) family, expressed on all hematopoietic cells except mature erythrocytes and platelets. There are different isoforms of CD45 that arise from variable splicing of exons 4, 5, and 6, which encode A, B, and C determinants, respectively. CD45 plays a key role in TCR and BCR signal transduction. These isoforms are very specific to the activation and maturation state of the cell as well as cell type. The primary ligands for CD45 are galectin-1, CD2, CD3, CD4, TCR, CD22, and Thy-1.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse thymus or spleen
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C.
Application

FC - Quality tested
IHC-F, CyTOF® - Verified
IP, CMCD, IHC, WB - Reported in the literature, not verified in house
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Application Notes

Clone 30-F11 reacts with all isoforms and both CD45.1 and CD45.2 alloantigens of CD45.

Additional reported applications (for relevant formats) include: immunoprecipitation3, complement-dependent cytotoxicity1,5, immunohistochemistry (acetone-fixed frozen sections, zinc-fixed paraffin-embedded sections and formalin-fixed paraffin-embedded sections)4,6, Western blotting7, and spatial biology (IBEX)10,11. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 103163 and 103164).

Application References
  1. Podd BS, et al. 2006. J. Immunol. 176:6532. (FC, CMCD) PubMed
  2. Haynes NM, et al. 2007. J. Immunol. 179:5099. (FC)
  3. Ledbetter JA, et al. 1979. Immunol. Rev. 47:63. (IP)
  4. Simon DI, et al. 2000. J. Clin. Invest. 105:293. (IHC)
  5. Seaman WE. 1983. J. Immunol. 130:1713. (CMCD)
  6. Cornet A, et al. 2001. P. Natl. Acad. Sci. USA 98:13306. (IHC)
  7. Tsuboi S and Fukuda M. 1998. J. Biol. Chem. 273:30680. (WB) PubMed
  8. Liu F, et al. 2012. Blood. 119:3295. PubMed
  9. Pelletier AN, et al. 2012. J. Immunol. 188:5561. PubMed
  10. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  11. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Davies M, et al. 2017. PLoS Pathogens. 13(6):e1006435. PubMed
  2. Axelrod HD, et al. 2019. Mol Cancer Res. 17:356. PubMed
  3. Schneider H, et al. 2017. J Neurochem. 140:170. PubMed
  4. Shafer MER, et al. 2017. Stem Cell Reports. 1.040277778. PubMed
  5. Arnold IC, et al. 2019. PLoS Pathog. 15:e1007866. PubMed
  6. Wolf Y, et al. 2017. J Exp Med. 214:905. PubMed
  7. Tarazi S, et al. 2022. Cell. 185:3290. PubMed
  8. Zhao Q, et al. 2023. Signal Transduct Target Ther. 8:40. PubMed
  9. Wang Y, et al. 2023. J Neuroinflammation. 20:41. PubMed
  10. García Fallit M, et al. 2023. Viruses. 15:. PubMed
  11. Xu J, et al. 2023. Discov Oncol. 14:68. PubMed
  12. Rafaiee R, et al. 2023. Bioimpacts. 13:97. PubMed
  13. Hutton C, et al. 2021. Cancer Cell. 39:1227. PubMed
  14. Li F, et al. 2020. EMBO J. 39:e103205. PubMed
  15. Liu CJ, et al. 2020. Neuro Oncol. 22:1276. PubMed
  16. Tremblay M, et al. 2020. Elife. 9: . PubMed
  17. Malinczak CA, et al. 2021. J Immunol. 206:1315. PubMed
  18. Li H, et al. 2022. Cancer Cell. 40:36. PubMed
  19. Ozga AJ, et al. 2022. Immunity. 55:82. PubMed
  20. Moore J, et al. 2022. Cancer Res. 82:365. PubMed
  21. Park JY, et al. 2022. Cell Rep. 38:110219. PubMed
  22. Valet C, et al. 2022. J Clin Invest. 132: . PubMed
  23. Lee NK, et al. 2022. Biomedicines. 10: . PubMed
  24. Moore AR, et al. 2022. Cell Rep. 41:111651. PubMed
  25. Li S, et al. 2022. Nat Commun. 13:7371. PubMed
  26. Abby E, et al. 2023. Nat Genet. 55:232. PubMed
  27. Potempa M, et al. 2022. J Immunol. 208:1742. PubMed
  28. Blomberg E, et al. 2022. Neurooncol Adv. 4:vdac148. PubMed
  29. Murai K, et al. 2022. Nat Commun. 13:6206. PubMed
  30. Hernández-Santana YE, et al. 2020. Life Sci Alliance. 3:00. PubMed
  31. Claveria-Cabello A, et al. 2020. Cancers (Basel). 12:00. PubMed
  32. Vitiello GA, et al. 2018. Clin Cancer Res. 24:972. PubMed
  33. Rothchild AC, et al. 2019. Sci Immunol. 4:eaaw6693. PubMed
  34. Widjaja AA, et al. 2019. Gastroenterology. 157:777. PubMed
  35. Kondo H, et al. 2020. J Biol Chem. 295:1658. PubMed
  36. Fernandes V, et al. 2020. PLoS Pathog. 16:e1008464. PubMed
  37. Nguyen R, et al. 2021. Cancer Immunol Immunother. 70:721. PubMed
  38. Wan Mohd Zawawi WFA, et al. 2021. Sci Rep. 11:10278. PubMed
  39. Maestro S, et al. 2021. Viruses. 13: . PubMed
  40. Reglero-Real N, et al. 2021. Immunity. :. PubMed
  41. Chamberlin T, et al. 2020. Cancer Research. 80(20):4465-4475. PubMed
  42. Li X, et al. 2020. Cell Rep. 31:107765. PubMed
  43. Moon H et al. 2017. Cell stem cell. 21(5):665-678 . PubMed
  44. Rieck M, et al. 2017. Eur J Immunol. 47:677. PubMed
  45. Ajona D, et al. 2017. Cancer Discov. 0.773611111. PubMed
  46. Goel S, et al. 2017. Nature. 548:471. PubMed
  47. Wang W, et al. 2018. Cancer Cell. 34:757. PubMed
  48. Paulo E, et al. 2018. Sci Rep. 8:11001. PubMed
  49. Arnold IC, et al. 2018. J Exp Med. 215:2055. PubMed
  50. Heinrich A, et al. 2021. Cell Rep. 37:109885. PubMed
  51. Cooper STE, et al. 2022. Int J Mol Sci. 23:. PubMed
  52. Deppermann C, et al. 2020. J Exp Med. 217:. PubMed
  53. Lee S, et al. 2020. Cell Host & Microbe. 27(6):937-949. PubMed
  54. Thulasingam S, et al. 2019. Int J Mol Sci. 20. PubMed
  55. Gao J, et al. 2017. Oncol Lett. 14:2954. PubMed
  56. Starossom SC, et al. 2019. Nat Commun. 10:217. PubMed
  57. Dertschnig S, et al. 2020. J Clin Invest. 130:1896. PubMed
  58. Gao H, et al. 2021. J Virol. :. PubMed
  59. Dienz O, et al. 2020. J Immunol. 204:1521. PubMed
  60. Karhadkar TR, et al. 2021. J Pharmacol Exp Ther. 376:106. PubMed
  61. Liu X, et al. 2020. Nature. . PubMed
  62. Altshuler A, et al. 2021. Cell Stem Cell. 28(7):1248-1261.e8. PubMed
  63. Parlanti P, et al. 2020. Exp Eye Res. 194:107998. PubMed
  64. Zabaleta N, et al. 2018. Nat Commun. 9:5454. PubMed
  65. Zhu F, et al. 2019. J Immunol. 203:2644. PubMed
  66. Li Y et al. 2019. Endocrinology. 160(4):938-946 . PubMed
  67. Murad JP, et al. 2018. Front Immunol. 1.95. PubMed
  68. Go DM, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:715. PubMed
  69. Wang G, et al. 2021. Nat Commun. 12:5733. PubMed
  70. Quintana E, et al. 2020. Cancer Res. 80:2889. PubMed
  71. Stefanescu C, et al. 2021. Front Oncol. 11:765151. PubMed
  72. Paprckova D, et al. 2022. Front Immunol. 13:1009198. PubMed
  73. Schafflick D, et al. 2020. Nat Commun. 247:11. PubMed
  74. Podd B, et al. 2006. J Immunol. 176:6532. PubMed
  75. Hitchcock JR, et al. 2020. FEBS J. 287:250. PubMed
  76. McLeod RL, et al. 2018. Oncotarget. 9:34459. PubMed
  77. Sutton C, et al. 2017. Nat Commun.. 10.1038/s41467-017-02111-0. PubMed
  78. Janghorban M, et al. 2022. Cancer Res. 82:885. PubMed
  79. Jackson JW, et al. 2021. Mol Ther Oncolytics. 22:444. PubMed
  80. Mayer KA, et al. 2021. FASEB J. 35:e21217. PubMed
  81. Delgobo M, et al. 2021. Front Immunol. 12:584538. PubMed
  82. Baraibar-Churio A, et al. 2021. Life (Basel). 11:. PubMed
  83. Nam J, et al. 2021. Front Cell Neurosci. 15:640084. PubMed
  84. Park S, et al. 2021. Nat Cell Biol. 23:476. PubMed
  85. Rhee S, et al. 2018. Nat Commun. 9:368. PubMed
  86. Finn J et al. 2019. Cell reports. 26(11):2942-2954 . PubMed
  87. Nolin JD, et al. 2017. JCI Insight. 2:e94929. PubMed
  88. Fiege JK, et al. 2019. PLoS Pathog. 15:e1008077. PubMed
  89. Silvestre-Roig C, et al. 2019. Nature. 569:236. PubMed
  90. Melchor SJ, et al. 2020. Sci Rep. 10:15724. PubMed
  91. O'Dea KP, et al. 2020. J Extracell Vesicles. 9:1706708. PubMed
  92. Baluk P, et al. 2020. Am J Pathol. 190:2355. PubMed
  93. Suzuki Y, et al. 2021. FEBS Open Bio. 11:2619. PubMed
  94. Gil-Melgosa L, et al. 2021. Biomedicines. 10:. PubMed
  95. Hagan AS, et al. 2020. Development. 147:00:00. PubMed
  96. Seelige R, et al. 2018. Sci Rep. 8:13670. PubMed
  97. Yoshihara S, et al. 2019. Front Immunol. 0.545833333. PubMed
  98. Mrdjen D et al. 2018. Immunity. 48(2):380-395 . PubMed
  99. He LD, et al. 2021. EMBO Rep. 22:e52196. PubMed
  100. Yim AKY, et al. 2022. Nat Neurosci. 25:238. PubMed
  101. Singh PP, et al. 2021. Ocul Surf. 21:271. PubMed
  102. Cassidy BR, et al. 2020. J Neuroinflammation. 17:259. PubMed
  103. Karhadkar TR, et al. 2021. PLoS One. 16:e0245924. PubMed
  104. Gereke M, et al. 2012. J Vis Exp. 70: 4322. PubMed
  105. Peralta Ramos JM, et al. 2017. Front Immunol. 1.490277778. PubMed
  106. Ito S, et al. 2020. PLoS One. 15:e0229888. PubMed
  107. Latasa M, et al. 2010. PLoS One. 5:e15690. PubMed
  108. Progatzky F, et al. 2021. Nature. 599:125. PubMed
  109. Bruno KA, et al. 2021. Int J Mol Sci. 22:. PubMed
  110. Crawford LB, et al. 2020. Microorganisms. 8:. PubMed
  111. Liu H, et al. 2020. J Immunol. 205:1207. PubMed
  112. Shokirova H, et al. 2021. Sci Rep. 11:8647. PubMed
  113. Brown IK, et al. 2021. PLoS Pathog. 17:e1009602. PubMed
  114. Fu H, et al. 2020. Front Immunol. 11:595813. PubMed
  115. Qiu X, et al. 2018. Lab Chip. 18:2776. PubMed
  116. Tsubaki T, et al. 2018. Oncotarget. 9:11209. PubMed
  117. Hoves S, et al. 2018. J Exp Med. 215:859. PubMed
  118. Vu LT, et al. 2019. J Extracell Vesicles. 8:1599680. PubMed
  119. Jones KB et al. 2018. Cell stem cell. 24(1):183-192 . PubMed
  120. Zhong L, et al. 2022. JCI Insight. 7:. PubMed
  121. Kenswil KJG, et al. 2021. Cell Stem Cell. 28(4):653-670.e11. PubMed
  122. Zareie P, et al. 2017. J Neuroinflammation. 0.630555556. PubMed
  123. Murai K et al. 2018. Cell stem cell. 23(5):687-699 . PubMed
  124. Morita S et al. 2017. Cell metabolism. 25(4):883-897 . PubMed
  125. Sheppard S, et al. 2018. Front Immunol. 1.630555556. PubMed
  126. Davies CL, et al. 2019. Front Immunol. 10:1048. PubMed
  127. Paharik AE, et al. 2017. Cell Host Microbe. 22:746. PubMed
  128. Johnson SA, et al. 2021. Eur J Immunol. 51:3228. PubMed
  129. Schuler CF, et al. 2020. Allergy. 75:2279. PubMed
  130. Yoon S, et al. 2020. Antioxidants (Basel). 10:. PubMed
  131. Hashimoto M, et al. 2021. J Neurochem. 156:834. PubMed
  132. Tao H, et al. 2021. Front Immunol. 12:623280. PubMed
  133. Scur M, et al. 2022. Nat Commun. 13:7272. PubMed
  134. Nikolaou K, et al. 2014. EMBO J. 34:430. PubMed
  135. Matsuo K, et al. 2018. J Invest Dermatol. 138:1764. PubMed
  136. Bar O, et al. 2020. Fluids Barriers CNS. 17:27. PubMed
  137. Langer V, et al. 2019. J Clin Invest. 129:4691. PubMed
  138. Poulos MG, et al. 2017. J Clin Invest. 127:4163. PubMed
  139. Janela B, et al. 2019. Immunity. 50:1069. PubMed
  140. Lopes N, et al. 2021. Nat Immunol. 22:179. PubMed
  141. Perdigoto AL, et al. 2022. JCI Insight. 7:. PubMed
  142. Ejima R, et al. 2021. Nutrients. 13:. PubMed
  143. Hu CF, et al. 2021. Front Immunol. 12:638381. PubMed
  144. Karhadkar TR, et al. 2020. bioRxiv. . PubMed
  145. Chen Q, et al. 2021. STAR Protocols. 2(1):100241. PubMed
  146. Baluk P, et al. 2018. Methods Mol Biol. 1846:161. PubMed
  147. Fino KK, et al. 2017. Sci Rep. 5.334722222. PubMed
  148. Mensurado S, et al. 2018. PLoS Biol. 16:e2004990. PubMed
  149. Geng T, et al. 2021. J Infect Dis. 223:2186. PubMed
  150. Ishigaki K, et al. 2021. Sci Rep. 11:13958. PubMed
  151. Tsukui H, et al. 2020. BMC Cancer. 20:411. PubMed
  152. Somasundaram R, et al. 2021. Blood. 137:3037. PubMed
  153. Prizant H, et al. 2021. Cell Reports. 36:109523. PubMed
  154. Yu W, et al. 2020. J Clin Invest. . PubMed
  155. Kim D, et al. 2019. Immune Netw. 19:e32. PubMed
  156. Chen X, et al. 2019. Methods Mol Biol. 2048:131. PubMed
  157. Nagatake T, et al. 2018. J Allergy Clin Immunol. 142:470. PubMed
  158. Moon H, et al. 2019. Nat Commun. 10:2225. PubMed
  159. Wang Z, et al. 2021. Drug Discov Ther. 14:304. PubMed
  160. Levy BD, et al. 2020. J Allergy Clin Immunol. 145:335. PubMed
  161. Seo SU, et al. 2021. Front Immunol. 12:697162. PubMed
  162. Roussey JA, et al. 2017. J Immunol. 199:3535. PubMed
  163. Tamburini BAJ, et al. 2019. Front Immunol. 10:1036. PubMed
  164. Dora D, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:1617. PubMed
  165. Fahy N, et al. 2021. Front Immunol. 12:715267. PubMed
  166. Brownlie D, et al. 2021. J Immunother Cancer. 9:. PubMed
  167. Cha J, et al. 2015. J Biol Chem. 290:15337. PubMed
  168. Mori Y, et al. 2021. Diabetes and Vascular Disease Research. 18(3):14791641211027324. PubMed
  169. Rincón E, et al. 2017. Oncotarget. 8:45415. PubMed
  170. Deng W et al. 2019. Cell reports. 27(6):1755-1768 . PubMed
  171. Van Der Zande HJP, et al. 2021. FASEB J. 35:e21331. PubMed
  172. Penny HL, et al. 2021. Int J Mol Sci. 22:. PubMed
  173. Chao Y, et al. 2020. Sci Adv. 6:eaaz4204. PubMed
  174. Lee YJ, et al. 2018. Front Microbiol. 9:83. PubMed
  175. Heinrich A, et al. 2020. Cell Rep. 31:107513. PubMed
  176. Parodi B, et al. 2021. Front Immunol. 12:655212. PubMed
  177. Mohrin M, et al. 2021. Aging Cell. 20:e13313. PubMed
  178. Cané S, et al. 2021. J Immunother Cancer. 9:. PubMed
  179. Udumula MP, et al. 2021. Mol Metab. 53:101272. PubMed
  180. DeFalco T, et al. 2014. Proc Natl Acad Sci U S A. 111:2384. PubMed
  181. Li Y, et al. 2020. Elife. 9:00. PubMed
  182. Diao J, et al. 2018. J Immunol. 201:1306. PubMed
  183. Pushalkar S, et al. 2018. Cancer Discov. 0.613194444. PubMed
  184. Burton OT, et al. 2018. Clin Exp Allergy. 48:288. PubMed
  185. Stokes KL, et al. 2019. Oncogenesis. 8:24. PubMed
  186. Krenzlin H, et al. 2019. J Clin Invest. 130:1671. PubMed
  187. Winter C, et al. 2018. Cell Metab. 28:175. PubMed
  188. Huppé CA, et al. 2018. Mucosal Immunol. 0.536111111. PubMed
  189. Van Winkle JA, et al. 2020. J Virol. 94:. PubMed
  190. Maier B, et al. 2020. Nature. 580:257. PubMed
  191. Wang J, et al. 2021. Am J Cancer Res. 11:2005. PubMed
  192. Aikawa S, et al. 2020. Cell Death Differ. 1489:27. PubMed
  193. Bernard S, et al. 2018. J Mammary Gland Biol Neoplasia. 23:249. PubMed
  194. Leist SR, et al. 2019. PLoS One. 14:e0220126. PubMed
  195. Zhang J, et al. 2019. Onco Targets Ther. 12:4985. PubMed
  196. Hassel C, et al. 2021. Front Immunol. 12:754661. PubMed
  197. Obst J, et al. 2020. Front Immunol. 11:579000. PubMed
  198. Dubik M, et al. 2021. Front Neurosci. 15:682451. PubMed
  199. Kästle M, et al. 2020. Cell Commun Signal. 183:18. PubMed
  200. Shao Y, et al. 2017. Onco Targets Ther. 10:2675. PubMed
  201. He X, et al. 2017. Cancer Biol Ther. 0.815277778. PubMed
  202. Haber AL, et al. 2017. Nature. 551:333. PubMed
  203. Emrick JJ, et al. 2018. Proc Natl Acad Sci U S A. 115:E12091. PubMed
  204. Seehus CR, et al. 2017. Nat Commun. 8:1900. PubMed
  205. Cédile O, Wlodarczyk A, and Owens T 2017. APMIS.. 10.1111/apm.12740. PubMed
  206. Wilke JBH, et al. 2021. Mol Psychiatry. 26:7746. PubMed
  207. Umeda M, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  208. Kästele V, et al. 2021. Mucosal Immunol. 14:717. PubMed
  209. Davies M, et al. 2017. PLoS Pathogens. 13(6):e1006435. PubMed
  210. Axelrod HD, et al. 2019. Mol Cancer Res. 17:356. PubMed
  211. Schneider H, et al. 2017. J Neurochem. 140:170. PubMed
  212. Shafer MER, et al. 2017. Stem Cell Reports. 1.040277778. PubMed
  213. Arnold IC, et al. 2019. PLoS Pathog. 15:e1007866. PubMed
  214. Wolf Y, et al. 2017. J Exp Med. 214:905. PubMed
  215. Tarazi S, et al. 2022. Cell. 185:3290. PubMed
  216. Zhao Q, et al. 2023. Signal Transduct Target Ther. 8:40. PubMed
  217. Wang Y, et al. 2023. J Neuroinflammation. 20:41. PubMed
  218. García Fallit M, et al. 2023. Viruses. 15:. PubMed
  219. Xu J, et al. 2023. Discov Oncol. 14:68. PubMed
  220. Rafaiee R, et al. 2023. Bioimpacts. 13:97. PubMed
  221. Hutton C, et al. 2021. Cancer Cell. 39:1227. PubMed
  222. Li F, et al. 2020. EMBO J. 39:e103205. PubMed
  223. Liu CJ, et al. 2020. Neuro Oncol. 22:1276. PubMed
  224. Tremblay M, et al. 2020. Elife. 9: . PubMed
  225. Malinczak CA, et al. 2021. J Immunol. 206:1315. PubMed
  226. Li H, et al. 2022. Cancer Cell. 40:36. PubMed
  227. Ozga AJ, et al. 2022. Immunity. 55:82. PubMed
  228. Moore J, et al. 2022. Cancer Res. 82:365. PubMed
  229. Park JY, et al. 2022. Cell Rep. 38:110219. PubMed
  230. Valet C, et al. 2022. J Clin Invest. 132: . PubMed
  231. Lee NK, et al. 2022. Biomedicines. 10: . PubMed
  232. Moore AR, et al. 2022. Cell Rep. 41:111651. PubMed
  233. Li S, et al. 2022. Nat Commun. 13:7371. PubMed
  234. Abby E, et al. 2023. Nat Genet. 55:232. PubMed
  235. Potempa M, et al. 2022. J Immunol. 208:1742. PubMed
  236. Blomberg E, et al. 2022. Neurooncol Adv. 4:vdac148. PubMed
  237. Murai K, et al. 2022. Nat Commun. 13:6206. PubMed
  238. Hernández-Santana YE, et al. 2020. Life Sci Alliance. 3:00. PubMed
  239. Claveria-Cabello A, et al. 2020. Cancers (Basel). 12:00. PubMed
  240. Vitiello GA, et al. 2018. Clin Cancer Res. 24:972. PubMed
  241. Rothchild AC, et al. 2019. Sci Immunol. 4:eaaw6693. PubMed
  242. Widjaja AA, et al. 2019. Gastroenterology. 157:777. PubMed
  243. Kondo H, et al. 2020. J Biol Chem. 295:1658. PubMed
  244. Fernandes V, et al. 2020. PLoS Pathog. 16:e1008464. PubMed
  245. Nguyen R, et al. 2021. Cancer Immunol Immunother. 70:721. PubMed
  246. Wan Mohd Zawawi WFA, et al. 2021. Sci Rep. 11:10278. PubMed
  247. Maestro S, et al. 2021. Viruses. 13: . PubMed
  248. Reglero-Real N, et al. 2021. Immunity. :. PubMed
  249. Chamberlin T, et al. 2020. Cancer Research. 80(20):4465-4475. PubMed
  250. Li X, et al. 2020. Cell Rep. 31:107765. PubMed
  251. Moon H et al. 2017. Cell stem cell. 21(5):665-678 . PubMed
  252. Rieck M, et al. 2017. Eur J Immunol. 47:677. PubMed
  253. Ajona D, et al. 2017. Cancer Discov. 0.773611111. PubMed
  254. Goel S, et al. 2017. Nature. 548:471. PubMed
  255. Wang W, et al. 2018. Cancer Cell. 34:757. PubMed
  256. Paulo E, et al. 2018. Sci Rep. 8:11001. PubMed
  257. Arnold IC, et al. 2018. J Exp Med. 215:2055. PubMed
  258. Heinrich A, et al. 2021. Cell Rep. 37:109885. PubMed
  259. Cooper STE, et al. 2022. Int J Mol Sci. 23:. PubMed
  260. Deppermann C, et al. 2020. J Exp Med. 217:. PubMed
  261. Lee S, et al. 2020. Cell Host & Microbe. 27(6):937-949. PubMed
  262. Thulasingam S, et al. 2019. Int J Mol Sci. 20. PubMed
  263. Gao J, et al. 2017. Oncol Lett. 14:2954. PubMed
  264. Starossom SC, et al. 2019. Nat Commun. 10:217. PubMed
  265. Dertschnig S, et al. 2020. J Clin Invest. 130:1896. PubMed
  266. Gao H, et al. 2021. J Virol. :. PubMed
  267. Dienz O, et al. 2020. J Immunol. 204:1521. PubMed
  268. Karhadkar TR, et al. 2021. J Pharmacol Exp Ther. 376:106. PubMed
  269. Liu X, et al. 2020. Nature. . PubMed
  270. Altshuler A, et al. 2021. Cell Stem Cell. 28(7):1248-1261.e8. PubMed
  271. Parlanti P, et al. 2020. Exp Eye Res. 194:107998. PubMed
  272. Zabaleta N, et al. 2018. Nat Commun. 9:5454. PubMed
  273. Zhu F, et al. 2019. J Immunol. 203:2644. PubMed
  274. Li Y et al. 2019. Endocrinology. 160(4):938-946 . PubMed
  275. Murad JP, et al. 2018. Front Immunol. 1.95. PubMed
  276. Go DM, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:715. PubMed
  277. Wang G, et al. 2021. Nat Commun. 12:5733. PubMed
  278. Quintana E, et al. 2020. Cancer Res. 80:2889. PubMed
  279. Stefanescu C, et al. 2021. Front Oncol. 11:765151. PubMed
  280. Paprckova D, et al. 2022. Front Immunol. 13:1009198. PubMed
  281. Schafflick D, et al. 2020. Nat Commun. 247:11. PubMed
  282. Podd B, et al. 2006. J Immunol. 176:6532. PubMed
  283. Hitchcock JR, et al. 2020. FEBS J. 287:250. PubMed
  284. McLeod RL, et al. 2018. Oncotarget. 9:34459. PubMed
  285. Sutton C, et al. 2017. Nat Commun.. 10.1038/s41467-017-02111-0. PubMed
  286. Janghorban M, et al. 2022. Cancer Res. 82:885. PubMed
  287. Jackson JW, et al. 2021. Mol Ther Oncolytics. 22:444. PubMed
  288. Mayer KA, et al. 2021. FASEB J. 35:e21217. PubMed
  289. Delgobo M, et al. 2021. Front Immunol. 12:584538. PubMed
  290. Baraibar-Churio A, et al. 2021. Life (Basel). 11:. PubMed
  291. Nam J, et al. 2021. Front Cell Neurosci. 15:640084. PubMed
  292. Park S, et al. 2021. Nat Cell Biol. 23:476. PubMed
  293. Rhee S, et al. 2018. Nat Commun. 9:368. PubMed
  294. Finn J et al. 2019. Cell reports. 26(11):2942-2954 . PubMed
  295. Nolin JD, et al. 2017. JCI Insight. 2:e94929. PubMed
  296. Fiege JK, et al. 2019. PLoS Pathog. 15:e1008077. PubMed
  297. Silvestre-Roig C, et al. 2019. Nature. 569:236. PubMed
  298. Melchor SJ, et al. 2020. Sci Rep. 10:15724. PubMed
  299. O'Dea KP, et al. 2020. J Extracell Vesicles. 9:1706708. PubMed
  300. Baluk P, et al. 2020. Am J Pathol. 190:2355. PubMed
  301. Suzuki Y, et al. 2021. FEBS Open Bio. 11:2619. PubMed
  302. Gil-Melgosa L, et al. 2021. Biomedicines. 10:. PubMed
  303. Hagan AS, et al. 2020. Development. 147:00:00. PubMed
  304. Seelige R, et al. 2018. Sci Rep. 8:13670. PubMed
  305. Yoshihara S, et al. 2019. Front Immunol. 0.545833333. PubMed
  306. Mrdjen D et al. 2018. Immunity. 48(2):380-395 . PubMed
  307. He LD, et al. 2021. EMBO Rep. 22:e52196. PubMed
  308. Yim AKY, et al. 2022. Nat Neurosci. 25:238. PubMed
  309. Singh PP, et al. 2021. Ocul Surf. 21:271. PubMed
  310. Cassidy BR, et al. 2020. J Neuroinflammation. 17:259. PubMed
  311. Karhadkar TR, et al. 2021. PLoS One. 16:e0245924. PubMed
  312. Gereke M, et al. 2012. J Vis Exp. 70: 4322. PubMed
  313. Peralta Ramos JM, et al. 2017. Front Immunol. 1.490277778. PubMed
  314. Ito S, et al. 2020. PLoS One. 15:e0229888. PubMed
  315. Latasa M, et al. 2010. PLoS One. 5:e15690. PubMed
  316. Progatzky F, et al. 2021. Nature. 599:125. PubMed
  317. Bruno KA, et al. 2021. Int J Mol Sci. 22:. PubMed
  318. Crawford LB, et al. 2020. Microorganisms. 8:. PubMed
  319. Liu H, et al. 2020. J Immunol. 205:1207. PubMed
  320. Shokirova H, et al. 2021. Sci Rep. 11:8647. PubMed
  321. Brown IK, et al. 2021. PLoS Pathog. 17:e1009602. PubMed
  322. Fu H, et al. 2020. Front Immunol. 11:595813. PubMed
  323. Qiu X, et al. 2018. Lab Chip. 18:2776. PubMed
  324. Tsubaki T, et al. 2018. Oncotarget. 9:11209. PubMed
  325. Hoves S, et al. 2018. J Exp Med. 215:859. PubMed
  326. Vu LT, et al. 2019. J Extracell Vesicles. 8:1599680. PubMed
  327. Jones KB et al. 2018. Cell stem cell. 24(1):183-192 . PubMed
  328. Zhong L, et al. 2022. JCI Insight. 7:. PubMed
  329. Kenswil KJG, et al. 2021. Cell Stem Cell. 28(4):653-670.e11. PubMed
  330. Zareie P, et al. 2017. J Neuroinflammation. 0.630555556. PubMed
  331. Murai K et al. 2018. Cell stem cell. 23(5):687-699 . PubMed
  332. Morita S et al. 2017. Cell metabolism. 25(4):883-897 . PubMed
  333. Sheppard S, et al. 2018. Front Immunol. 1.630555556. PubMed
  334. Davies CL, et al. 2019. Front Immunol. 10:1048. PubMed
  335. Paharik AE, et al. 2017. Cell Host Microbe. 22:746. PubMed
  336. Johnson SA, et al. 2021. Eur J Immunol. 51:3228. PubMed
  337. Schuler CF, et al. 2020. Allergy. 75:2279. PubMed
  338. Yoon S, et al. 2020. Antioxidants (Basel). 10:. PubMed
  339. Hashimoto M, et al. 2021. J Neurochem. 156:834. PubMed
  340. Tao H, et al. 2021. Front Immunol. 12:623280. PubMed
  341. Scur M, et al. 2022. Nat Commun. 13:7272. PubMed
  342. Nikolaou K, et al. 2014. EMBO J. 34:430. PubMed
  343. Matsuo K, et al. 2018. J Invest Dermatol. 138:1764. PubMed
  344. Bar O, et al. 2020. Fluids Barriers CNS. 17:27. PubMed
  345. Langer V, et al. 2019. J Clin Invest. 129:4691. PubMed
  346. Poulos MG, et al. 2017. J Clin Invest. 127:4163. PubMed
  347. Janela B, et al. 2019. Immunity. 50:1069. PubMed
  348. Lopes N, et al. 2021. Nat Immunol. 22:179. PubMed
  349. Perdigoto AL, et al. 2022. JCI Insight. 7:. PubMed
  350. Ejima R, et al. 2021. Nutrients. 13:. PubMed
  351. Hu CF, et al. 2021. Front Immunol. 12:638381. PubMed
  352. Karhadkar TR, et al. 2020. bioRxiv. . PubMed
  353. Chen Q, et al. 2021. STAR Protocols. 2(1):100241. PubMed
  354. Baluk P, et al. 2018. Methods Mol Biol. 1846:161. PubMed
  355. Fino KK, et al. 2017. Sci Rep. 5.334722222. PubMed
  356. Mensurado S, et al. 2018. PLoS Biol. 16:e2004990. PubMed
  357. Geng T, et al. 2021. J Infect Dis. 223:2186. PubMed
  358. Ishigaki K, et al. 2021. Sci Rep. 11:13958. PubMed
  359. Tsukui H, et al. 2020. BMC Cancer. 20:411. PubMed
  360. Somasundaram R, et al. 2021. Blood. 137:3037. PubMed
  361. Prizant H, et al. 2021. Cell Reports. 36:109523. PubMed
  362. Yu W, et al. 2020. J Clin Invest. . PubMed
  363. Kim D, et al. 2019. Immune Netw. 19:e32. PubMed
  364. Chen X, et al. 2019. Methods Mol Biol. 2048:131. PubMed
  365. Nagatake T, et al. 2018. J Allergy Clin Immunol. 142:470. PubMed
  366. Moon H, et al. 2019. Nat Commun. 10:2225. PubMed
  367. Wang Z, et al. 2021. Drug Discov Ther. 14:304. PubMed
  368. Levy BD, et al. 2020. J Allergy Clin Immunol. 145:335. PubMed
  369. Seo SU, et al. 2021. Front Immunol. 12:697162. PubMed
  370. Roussey JA, et al. 2017. J Immunol. 199:3535. PubMed
  371. Tamburini BAJ, et al. 2019. Front Immunol. 10:1036. PubMed
  372. Dora D, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:1617. PubMed
  373. Fahy N, et al. 2021. Front Immunol. 12:715267. PubMed
  374. Brownlie D, et al. 2021. J Immunother Cancer. 9:. PubMed
  375. Cha J, et al. 2015. J Biol Chem. 290:15337. PubMed
  376. Mori Y, et al. 2021. Diabetes and Vascular Disease Research. 18(3):14791641211027324. PubMed
  377. Rincón E, et al. 2017. Oncotarget. 8:45415. PubMed
  378. Deng W et al. 2019. Cell reports. 27(6):1755-1768 . PubMed
  379. Van Der Zande HJP, et al. 2021. FASEB J. 35:e21331. PubMed
  380. Penny HL, et al. 2021. Int J Mol Sci. 22:. PubMed
  381. Chao Y, et al. 2020. Sci Adv. 6:eaaz4204. PubMed
  382. Lee YJ, et al. 2018. Front Microbiol. 9:83. PubMed
  383. Heinrich A, et al. 2020. Cell Rep. 31:107513. PubMed
  384. Parodi B, et al. 2021. Front Immunol. 12:655212. PubMed
  385. Mohrin M, et al. 2021. Aging Cell. 20:e13313. PubMed
  386. Cané S, et al. 2021. J Immunother Cancer. 9:. PubMed
  387. Udumula MP, et al. 2021. Mol Metab. 53:101272. PubMed
  388. DeFalco T, et al. 2014. Proc Natl Acad Sci U S A. 111:2384. PubMed
  389. Li Y, et al. 2020. Elife. 9:00. PubMed
  390. Diao J, et al. 2018. J Immunol. 201:1306. PubMed
  391. Pushalkar S, et al. 2018. Cancer Discov. 0.613194444. PubMed
  392. Burton OT, et al. 2018. Clin Exp Allergy. 48:288. PubMed
  393. Stokes KL, et al. 2019. Oncogenesis. 8:24. PubMed
  394. Krenzlin H, et al. 2019. J Clin Invest. 130:1671. PubMed
  395. Winter C, et al. 2018. Cell Metab. 28:175. PubMed
  396. Huppé CA, et al. 2018. Mucosal Immunol. 0.536111111. PubMed
  397. Van Winkle JA, et al. 2020. J Virol. 94:. PubMed
  398. Maier B, et al. 2020. Nature. 580:257. PubMed
  399. Wang J, et al. 2021. Am J Cancer Res. 11:2005. PubMed
  400. Aikawa S, et al. 2020. Cell Death Differ. 1489:27. PubMed
  401. Bernard S, et al. 2018. J Mammary Gland Biol Neoplasia. 23:249. PubMed
  402. Leist SR, et al. 2019. PLoS One. 14:e0220126. PubMed
  403. Zhang J, et al. 2019. Onco Targets Ther. 12:4985. PubMed
  404. Hassel C, et al. 2021. Front Immunol. 12:754661. PubMed
  405. Obst J, et al. 2020. Front Immunol. 11:579000. PubMed
  406. Dubik M, et al. 2021. Front Neurosci. 15:682451. PubMed
  407. Kästle M, et al. 2020. Cell Commun Signal. 183:18. PubMed
  408. Shao Y, et al. 2017. Onco Targets Ther. 10:2675. PubMed
  409. He X, et al. 2017. Cancer Biol Ther. 0.815277778. PubMed
  410. Haber AL, et al. 2017. Nature. 551:333. PubMed
  411. Emrick JJ, et al. 2018. Proc Natl Acad Sci U S A. 115:E12091. PubMed
  412. Seehus CR, et al. 2017. Nat Commun. 8:1900. PubMed
  413. Cédile O, Wlodarczyk A, and Owens T 2017. APMIS.. 10.1111/apm.12740. PubMed
  414. Wilke JBH, et al. 2021. Mol Psychiatry. 26:7746. PubMed
  415. Umeda M, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  416. Kästele V, et al. 2021. Mucosal Immunol. 14:717. PubMed
RRID
AB_312966 (BioLegend Cat. No. 103101)
AB_312967 (BioLegend Cat. No. 103102)

Antigen Details

Structure
Protein tyrosine phosphatase (PTP) family, 180-240 kD
Distribution

All hematopoietic cells except mature erythrocytes and platelets

Function
Phosphatase, T and B cell activation
Ligand/Receptor
Galectin-1, CD2, CD3, CD4, TCR, CD22, Thy-1
Cell Type
B cells, Dendritic cells, Mesenchymal Stem Cells, Tregs
Biology Area
Cell Biology, Immunology, Inhibitory Molecules, Innate Immunity, Neuroscience, Neuroscience Cell Markers, Stem Cells
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Trowbridge IS, et al. 1993. Annu. Rev. Immunol. 12:85.
3. Kishihara K, et al. 1993. Cell 74:143.
4. Pulido R, et al. 1988. J. Immunol. 140:3851.

Gene ID
19264 View all products for this Gene ID
UniProt
View information about CD45 on UniProt.org

Other Formats

View All CD45 Reagents Request Custom Conjugation
Description Clone Applications
PE anti-mouse CD45 30-F11 FC
PE/Cyanine5 anti-mouse CD45 30-F11 FC
Purified anti-mouse CD45 30-F11 FC,IHC-F,CyTOF®,IP,CMCD,IHC,WB
PE/Cyanine7 anti-mouse CD45 30-F11 FC
PE/Dazzle™ 594 anti-mouse CD45 30-F11 FC
Brilliant Violet 711™ anti-mouse CD45 30-F11 FC
Brilliant Violet 785™ anti-mouse CD45 30-F11 FC
Brilliant Violet 650™ anti-mouse CD45 30-F11 FC
APC/Fire™ 750 anti-mouse CD45 30-F11 FC
Brilliant Violet 750™ anti-mouse CD45 30-F11 FC
TotalSeq™-A0096 anti-mouse CD45 30-F11 PG
TotalSeq™-B0096 anti-mouse CD45 30-F11 PG
Ultra-LEAF™ Purified anti-mouse CD45 30-F11 FC,CyTOF®,IP,CMCD,IHC,WB
Spark Blue™ 550 anti-mouse CD45 30-F11 FC
Spark NIR™ 685 anti-mouse CD45 30-F11 FC
TotalSeq™-C0096 anti-mouse CD45 30-F11 PG
Spark YG™ 570 anti-mouse CD45 30-F11 IHC-F
PE/Fire™ 640 anti-mouse CD45 30-F11 FC
APC/Fire™ 810 anti-mouse CD45 30-F11 FC
PE/Fire™ 700 anti-mouse CD45 30-F11 FC
APC anti-mouse CD45 30-F11 FC
Biotin anti-mouse CD45 30-F11 FC
FITC anti-mouse CD45 30-F11 FC
APC/Cyanine7 anti-mouse CD45 30-F11 FC
Alexa Fluor® 488 anti-mouse CD45 30-F11 FC,SB
Alexa Fluor® 647 anti-mouse CD45 30-F11 FC,ICC,IHC,3D IHC,SB
Pacific Blue™ anti-mouse CD45 30-F11 FC
Alexa Fluor® 700 anti-mouse CD45 30-F11 FC,SB
PerCP/Cyanine5.5 anti-mouse CD45 30-F11 FC
PerCP anti-mouse CD45 30-F11 FC
Alexa Fluor® 594 anti-mouse CD45 30-F11 IHC-F,FC,3D IHC
Brilliant Violet 421™ anti-mouse CD45 30-F11 FC,SB
Brilliant Violet 570™ anti-mouse CD45 30-F11 FC
Brilliant Violet 510™ anti-mouse CD45 30-F11 FC
Brilliant Violet 605™ anti-mouse CD45 30-F11 FC
Purified anti-mouse CD45 (Maxpar® Ready) 30-F11 FC,CyTOF®
Spark Violet™ 538 anti-mouse CD45 30-F11 FC
Spark YG™ 593 anti-mouse CD45 30-F11 FC
Spark Blue™ 574 anti-mouse CD45 Antibody 30-F11 FC
Spark Blue™ 515 anti-mouse CD45 30-F11 FC
Spark UV™ 387 anti-mouse CD45 30-F11 FC
PE/Fire™ 810 anti-mouse CD45 30-F11 FC
Spark PLUS UV395™ anti-mouse CD45 30-F11 FC
Spark Red™ 718 anti-mouse CD45 30-F11 FC
Spark YG™ 581 anti-mouse CD45 (Flexi-Fluor™) 30-F11 FC
Spark PLUS V475™ anti-mouse CD45 Antibody 30-F11 FC
StarBright UltraViolet 740 anti-mouse CD45 30-F11 FC
Go To Top Version: 3    Revision Date: 10/25/2018

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account